After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Most recently, Yahoo Finance reported about the stock as it publicized that United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, UTHR falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of United Therapeutics Corp is $11.66B. A total of 0.56 million shares were traded on the day, compared to an average of 400.19K shares.
In the most recent transaction, ROTHBLATT MARTINE A sold 15,000 shares of UTHR for 237.05 per share on Mar 22 ’24. After the transaction, the CHAIRPERSON & CEO now owns 130 company shares. In a previous transaction on Mar 21 ’24, ROTHBLATT MARTINE A sold 15,000 shares at 236.34 per share. UTHR shares that CHAIRPERSON & CEO owns now total 130.
Among the insiders who sold shares, MAHON PAUL A disposed of 6,000 shares on Mar 21 ’24 at a per-share price of $236.45. This resulted in the EVP & GENERAL COUNSEL holding 36,710 shares of UTHR after the transaction. In another insider transaction, ROTHBLATT MARTINE A sold 15,000 shares at $235.95 per share on Mar 20 ’24. Company shares held by the CHAIRPERSON & CEO now total 130.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, UTHR has a high of $261.54 and a low of $204.44.
As of this writing, UTHR has an earnings estimate of $5.65 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $6.53 per share and a lower estimate of $4.75. The company reported an EPS of $5.38 in the last quarter, which was 6.70% higher than expectations of $5.04.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. UTHR’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $800.00M in debt and $305.40M in liabilities at the time. Its Book Value Per Share was $127.23, while its Total Shareholder’s Equity was $3.96B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for UTHR is Buy with a score of 4.50.
